WASHINGTON, D.C. – Despite the fact that young people are the least affected by the COVID-19 virus and that shots come with serious adverse effects and deaths, federal public health officials and pharmaceutical companies race to vaccinate children.
Moderna announced yesterday that it submitted a request to the Food and Drug Administration (FDA) for emergency use authorization (EUA) for its two-dose COVID-19 injection for children ages six months to under six years old. On Tuesday, Pfizer and BioNTech submitted an application to the FDA for EUA for a booster dose of the Pfizer-BioNTech COVID-19 shot for children 5 through 11 years of age.
When it comes to COVID, public health officials have consistently downplayed and ignored natural immunity among children. Yet 81 research studies confirm that natural immunity to COVID is equal or superior to any “vaccine immunity.”
